PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
nkx3-1 | dr11_v1_chr8_-_50259448_50259448 | 0.37 | 2.0e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_11623063 Show fit | 17.28 |
ENSDART00000145653
|
glucagon a |
|
chr11_-_30636163 Show fit | 16.19 |
ENSDART00000140516
|
zgc:153665 |
|
chr8_-_40464935 Show fit | 13.19 |
ENSDART00000040013
|
myosin, light chain 7, regulatory |
|
chr19_-_5699703 Show fit | 13.08 |
ENSDART00000082050
|
zgc:174904 |
|
chr9_+_8396755 Show fit | 12.84 |
ENSDART00000043067
|
zgc:171776 |
|
chr24_-_26328721 Show fit | 11.68 |
ENSDART00000125468
|
apolipoprotein Db |
|
chr1_-_5542565 Show fit | 11.34 |
ENSDART00000160791
ENSDART00000103754 |
fibronectin 1b |
|
chr7_+_22680560 Show fit | 10.63 |
ENSDART00000133761
|
plac8 onzin related protein 4 |
|
chr11_-_5865744 Show fit | 10.48 |
ENSDART00000104360
|
guanidinoacetate N-methyltransferase |
|
chr17_+_24615091 Show fit | 9.35 |
ENSDART00000064739
|
ribosomal protein L13a |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 23.8 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
2.2 | 15.3 | GO:0006953 | acute-phase response(GO:0006953) |
2.2 | 13.2 | GO:0055014 | ventricular cardiac myofibril assembly(GO:0055005) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 12.1 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 11.7 | GO:0007568 | aging(GO:0007568) |
0.8 | 10.6 | GO:0006599 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
3.5 | 10.5 | GO:0006601 | creatine metabolic process(GO:0006600) creatine biosynthetic process(GO:0006601) |
0.1 | 10.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 10.0 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.0 | 9.8 | GO:0006955 | immune response(GO:0006955) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 110.6 | GO:0005576 | extracellular region(GO:0005576) |
0.4 | 19.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.9 | 14.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 10.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 10.4 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 9.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.4 | 7.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 7.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.6 | 7.1 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 7.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 25.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
4.0 | 19.8 | GO:0031769 | glucagon receptor binding(GO:0031769) |
0.1 | 17.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 12.7 | GO:0019843 | rRNA binding(GO:0019843) |
1.4 | 11.3 | GO:0043394 | glycoprotein binding(GO:0001948) proteoglycan binding(GO:0043394) |
0.8 | 10.6 | GO:0004111 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 8.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 8.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 7.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 7.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 7.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 7.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 6.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 5.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 5.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 4.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 4.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 3.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 19.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.8 | 17.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 10.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 9.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 7.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 7.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 6.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 5.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 5.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 5.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |